Was a big bargin below $4.
Forecast suggests ongoing OCF and NPAT growth.
In this COVID environment where everyone is downgrading or withdrawing guidance we have a solid pharmaceutical company with growing sales and a good portfolio of a patented product, an orphan drug and a range of generics which doing well in the Australiasian space.
Furthermore, their sales overseas are co-ordinated by pharmaceuticals already known in the respective regions so no need to try and form a name for themselves.
Was a big bargin below $4.Forecast suggests ongoing OCF and NPAT...
Add AFP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.60 |
Change
0.000(0.00%) |
Mkt cap ! $272.6M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2 | $2.62 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.80 | 1606 | 1 |
View Market Depth
| Last trade - 16.12pm 07/05/2024 (20 minute delay) ? |
| AFP (ASX) Chart |
Day chart unavailable